Life Sciences

Annual Reports Show Australian Companies Profit from Asian/Global Investments

🕔11/23/2005 9:28:48 AM

Summary of Australian Companies Profit Percentages offshore investments.

Read Full Article

Stem Cell Sciences Grants Lexicon Genetics Exclusive IRES Licence

🕔11/4/2005 10:55:28 AM

The board of Biotech Capital (ASX: BTC) announced that its investee company (Stem Cell Sciences plc ("SCS") has concluded an agreement with the US-Based company Lexicon Genetics ("Lexicon"). Lexicon is a biopharmaceutical company focused on the discovery and development of treatments for a range of human diseases primarily using its proprietary gene knock out technology.

Read Full Article

Latest Headlines